Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-27

Clinical Trial Update: A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit. [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 bioequivalence study comparing two nicotine replacement therapies in healthy adult smokers motivated to quit. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine replacement therapy A (nicotine replacement therapy)
  • Nicotine replacement therapy B (nicotine replacement therapy)

Snippet

Sponsor: McNeil AB | Conditions: Tobacco Dependence | Phase 1 | Status: COMPLETED